Foghorn Therapeutics Inc. (FHTX) Institutional Ownership

Ownership Summary

A total of 88 institutions have reported a stake in Foghorn Therapeutics Inc. (NASDAQ:FHTX) as of December 2025, according to recent 13F filings with the SEC.

• Institutional ownership in Foghorn Therapeutics edged down to 61.6% in December 2025, compared to 64.1% in September 2025.
• On a quarter-over-quarter basis, institutional holdings shifted by 4.33%, with a year-over-year no change in the count of filers.
• A review of institutional activity for Foghorn Therapeutics shows 43 of 88 filers increasing their positions, while 23 reduced their stake, and 22 remained unchanged.
• Collectively, institutional investors increased their stake in Foghorn Therapeutics to 39.33Mn shares as of December 2025, a change that is up by 1.63Mn shares quarter on quarter and down 924.02K shares year over year.
• The top institutional stake in Foghorn Therapeutics as of December 31, 2025 belongs to Flagship Pioneering, LLC, which owns 12.67Mn shares, or 19.86% of the company.
• Among the most significant buyers of Foghorn Therapeutics during December 2025 were AMERIPRISE FINANCIAL INC (607.67K), DEERFIELD MANAGEMENT COMPANY, L.P. (393.70K), RENAISSANCE TECHNOLOGIES LLC (179.50K), CITADEL ADVISORS LLC (170.25K), Squarepoint Ops LLC (104.97K).
• Leading sellers of Foghorn Therapeutics stock in December 2025 included Point72 Asset Management, L.P. (309.06K), Woodline Partners LP (87.07K), FMR LLC (77.68K), NORTHERN TRUST CORP (21.87K), DIADEMA PARTNERS LP (19.37K).
• The top 10 institutional holders of Foghorn Therapeutics for the quarter ending December 2025 included Flagship Pioneering, LLC (12.67Mn), FMR LLC (5.40Mn), BVF INC/IL (5.30Mn), DEERFIELD MANAGEMENT COMPANY, L.P. (3.65Mn), BlackRock, Inc. (2.35Mn), VANGUARD GROUP INC (1.93Mn), Euclidean Capital LLC (1.57Mn), GEODE CAPITAL MANAGEMENT, LLC (795.04K), Siren, L.L.C. (720.72K), STATE STREET CORP (618.67K).